Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
25
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 25 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells
Role: lead
Allergy Diagnostic Test Based on Microchip Technology
Role: lead
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
Role: lead
Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells
Role: lead
Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells
Role: lead
Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells
Role: lead
Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles
Role: lead
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
Role: lead
Treatment of Alopecia Using Follicular Stem Cells
Role: lead
Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells
Role: lead
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
Role: lead
Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells
Role: lead
Fertility Restoration Using Autologous Mesenchymal Stem Cells
Role: lead
Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients
Role: lead
Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells
Role: lead
Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells
Role: lead
Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction
Role: lead
Treatment of Recurrent Bladder Cancer With Dendritic Cells
Role: lead
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells
Role: lead
Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells
Role: lead